T1	Treatment 58 80	estramustine phosphate
T2	Treatment 88 152	low dose epirubicin with or without medroxyprogesterone acetate.
T3	Treatment 409 567	treated with estramustine phosphate, another with Epirubicin plus Medroxyprogesterone acetate (MPA), while the third arm consisted of Epirubicin plus placebo.
T4	Treatment 619 638	Epirubicin and MPA.
